Nurix Therapeutics, Inc.
Pharmaceutical Preparations · Brisbane, CA, United States
- PrincipalsArthur T SandsPresident, CEOChristine RingChief Legal OfficerGwenn HansenChief Scientific Officerand 2 more
- CompanyNurix Therapeutics, Inc.Brisbane, CA, United States
- Phone line+1 (415) 660-5320General business
Nurix Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker NRIX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Chief executive
Arthur T SandsPresident, CEO
Chair & board
Roger D DanseyDirector (Board)
Finance
Houte Hans vanChief Financial Officer
Legal
Christine RingChief Legal Officer
Everyone else on file (1)
Gwenn HansenChief Scientific Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Arthur T Sands — President, CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Christine Ring — Chief Legal Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Gwenn Hansen — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Houte Hans van — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
uniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capability